STAT News reported last month that Astra Zeneca agreed to provide the Medicaid program with discounted drug prices, supposedly in line with what it offers other comparably wealthy countries
Oral GLP-1 pills : The FDA approved Lilly's oral GLP-1 drug orforglipron (brand name Foundayo) on April 1, 2026 the first oral GLP-1 receptor agonist for weight management that can be taken any time of day without food restrictions
Weight management is influenced by many factors, including medical history, current medications, lifestyle, existing health conditions, and long-term health goals
Industry disclosure: Dr
L-Carnitine: overview, uses, side effects, precautions, interactions, dosing and reviews
This raised questions about whether GLP-1RAs could cause pancreatic effects beyond pancreatitis, including the development of PDAC